---
schema_version: "secwatch.filing_event.v1"
accession: "0001459839-25-000059"
form_type: "8-K"
ticker: "SIBN"
cik: "0001459839"
company_name: "SI-BONE, Inc."
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T17:04:23.702975+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SI-BONE Q1 revenue up 25% to $47.3M, posts positive adjusted EBITDA, raises FY guidance

## Summary
- Worldwide revenue $47.3M, up 24.9% YoY; U.S. revenue $44.8M, up 26.6%.
- Gross margin 79.7% vs 78.9% a year ago; net loss improved 40% to $6.5M ($0.15/share).
- Adjusted EBITDA positive $0.5M vs loss of $4.0M in Q1 2024; cash $144.4M, net cash usage down 31.7%.
- FY2025 revenue guidance raised to $193.5M-$197.5M (prior $193.5M-$195.5M); expects positive adjusted EBITDA for full year.
- Added 300 active U.S. physicians in Q1; CMS proposed NTAP for iFuse TORQ TNT up to $3,960/ procedure.

## SEC filing metadata
- accession: 0001459839-25-000059
- form_type: 8-K
- ticker: SIBN
- cik: 0001459839
- company_name: SI-BONE, Inc.
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1459839/000145983925000059/0001459839-25-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1459839/000145983925000059/sibn-20250505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001459839-25-000059
- JSON: https://secwatch.observer/filing/0001459839-25-000059.json
- Plain text: https://secwatch.observer/filing/0001459839-25-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.